Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The management of thrombosis in the antiphospholipid-antibody syndrome

Article Abstract:

Patients with the antiphospholipid-antibody syndrome may require long-term anticoagulation to prevent blood clots. The formation of blood clots in veins and arteries is common in this syndrome, which is characterized by the presence of antibodies against fats in cell membranes. Researchers divided 147 patients with antiphospholipid-antibody syndrome into six treatment groups: no treatment, treatment with aspirin alone, treatment with the anticoagulant drug warfarin at high or low doses, with or without aspirin. After follow-up ranging from one to 21 years, 101 patients developed a blood clot in a vein or artery. None of the patients taking high-dose warfarin and aspirin developed a blood clot, while recurrent blood clots occurred in all other treatment groups. Patients who stopped taking warfarin had a higher recurrence rate within six months than the patients who were never treated. Warfarin caused bleeding in 29 patients, which was easily controlled in 22.

Author: Hughes, Graham R.V., Khamashta, Munther A., Hunt, Beverley J., Cuadrado, Maria Jose, Mujic, Fedza, Taub, Nick A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995
Complications and side effects, Antiphospholipid syndrome, Thrombosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Oral anticoagulant therapy for the prevention of stroke

Article Abstract:

Warfarin is no better than aspirin in preventing a second stroke in stroke patients. About one third of all strokes occur in people who have already had one. For this reason, doctors continue to research new approaches for preventing recurring strokes.

Author: Powers, William J.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
Editorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

Article Abstract:

Warfarin and aspirin appear to be equally effective in preventing a second stroke in stroke patients, according to a study of 2,206 patients. The rate of major hemorrhage or bleeding was also similar for either treatment.

Author: Mohr, J.P., Thompson, J.L.P., Lazar, R.M., Levin, B., Sacco, R.L., Furie, K.L., Kistler, J.P., Albers, G.W., Pettigrew, L.C., Adams, H.P., Jr., Jackson, C.M., Pullicino, P.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Prevention, Aspirin, Warfarin, Stroke (Disease), Stroke
Similar abstracts:
  • Abstracts: The use of phosphate enemas in the treatment of constipation. Fluids, fibre and constipation
  • Abstracts: The immunopathogenesis of gastrointestinal and hepatobiliary diseases. Prospects for Research in Inflammatory Bowel Disease
  • Abstracts: Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes
  • Abstracts: Undercover agents. A traitor in the ranks. An end to innocence
  • Abstracts: Simulation of therapy in a model of nonhydropic and hydropic recipient in twin- twin transfusion syndrome. Fetal urine and amniotic fluid in monochorionic twins with twin-twin transfusion syndrome: simulations of therapy
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.